Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joanne, Ayriss"'
Autor:
Yariv Mazor, Chunning Yang, M Jack Borrok, Joanne Ayriss, Karen Aherne, Herren Wu, William F Dall'Acqua
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157788 (2016)
Antibody-mediated immune effector functions play an essential role in the anti-tumor efficacy of many therapeutic mAbs. While much of the effort to improve effector potency has focused on augmenting the interaction between the antibody-Fc and activat
Externí odkaz:
https://doaj.org/article/85ce56ebbd954746be46444af03771f4
Autor:
John Meekin, Haihong Zhong, Maureen Kennedy, Rosa A. Carrasco, Ronald Herbst, Sandrina Phipps, Binyam Bezabeh, R. James Christie, Karma Dacosta, David A. Tice, Emily E. Bosco, Jiping Zha, Rakesh Dixit, Partha S. Chowdhury, Joanne Ayriss, Qun Du, Zhan Xiao, Darrin Sabol, MaryJane Hinrichs, Cui Chen, Shannon Breen, Lee Brown, Molly Reed
Publikováno v:
Oncotarget
Despite recent advances in treatment, breast cancer remains the second-most common cause of cancer death among American women. A greater understanding of the molecular characteristics of breast tumors could ultimately lead to improved tumor-targeted
Autor:
M. Jack Borrok, Chunning Yang, William Dall'acqua, Herren Wu, Yariv Mazor, Karen Aherne, Joanne Ayriss
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 6, p e0157788 (2016)
PLoS ONE, Vol 11, Iss 6, p e0157788 (2016)
Antibody-mediated immune effector functions play an essential role in the anti-tumor efficacy of many therapeutic mAbs. While much of the effort to improve effector potency has focused on augmenting the interaction between the antibody-Fc and activat
Autor:
Joanne Ayriss, Anjaneyulu Dirisala, Shaoyi Chen, Stelios Florinas, Ryan Fleming, Ze Qi Xu, Herren Wu, Nazzareno Dimasi, Kazunori Kataoka, Changshou Gao, Ryan N. Gilbreth, Horacio Cabral, Marc Liu, R. James Christie, Lilian van Vlerken-Ysla
Publikováno v:
Biomacromolecules. 17(5)
Targeted nanomedicines are a promising technology for treatment of disease; however, preparation and characterization of well-defined protein-nanoparticle systems remain challenging. Here, we describe a platform technology to prepare antibody binding
Autor:
Chien-Tsun Kuan, Hailan Piao, Jinli Chang, Mika K. Kaneko, Jan-Eric Månsson, Vidyalakshmi Chandramohan, Roger E. McLendon, Pam Fredman, Darell D. Bigner, Joanne Ayriss, Charles N. Pegram, Yukinari Kato
Publikováno v:
Biochemical and Biophysical Research Communications. 391:750-755
The lacto-series gangliosides 3'-isoLM1 and 3',6'-isoLD1 have been identified as tumor-associated antigens whose formation is initiated by the Lc3-synthase. Until now, high-affinity IgG monoclonal antibodies (mAbs) against 3'-isoLM1 and 3',6'-isoLD1,
Publikováno v:
Journal of Proteome Research. 6:1072-1082
We have developed a screening method that has the potential to streamline the high-throughput analysis of affinity reagents for proteomic projects. By using multiplexed flow cytometry, we can simultaneously determine the relative expression levels, t
Autor:
Yulin Shou, Antonietta M. Lillo, Peter Pavlik, Andrew Bradbury, Joanne Ayriss, Steven W. Graves
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 4 (2012)
PLoS ONE, Vol 7, Iss 4 (2012)
There was an error in the by-line in the online version of the article. The sixth author, Peter Pavlik, was mistakenly excluded.
Autor:
Darell D. Bigner, Carol J. Wikstrand, Roger E. McLendon, Abraham Boskovitz, Anne F. Buckley, Eric S. Lipp, James E. Herndon, Michael R. Zalutsky, Charles N. Pegram, Joanne Ayriss, Chien-Tsun Kuan
Publikováno v:
Nuclear medicine and biology. 39(1)
Introduction Malignant glioma remains a significant therapeutic challenge, and immunotherapeutics might be a beneficial approach for these patients. A monoclonal antibody (MAb) specific for multiple molecular targets could expand the treatable patien
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 525
The development of high-throughput screening (HTS) technologies has become essential for initial characterization of recombinant antibodies and alternative affinity reagents, selected from large combinatorial libraries. Such binding ligands are routi
Publikováno v:
Therapeutic Antibodies ISBN: 9781934115923
The development of high-throughput screening (HTS) technologies has become essential for initial characterization of recombinant antibodies and alternative affinity reagents, selected from large combinatorial libraries. Such binding ligands are routi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e37af1a95e7a4e8c66119453e07f41c
https://doi.org/10.1007/978-1-59745-554-1_12
https://doi.org/10.1007/978-1-59745-554-1_12